Quibim
Whole-body medical imaging analysis
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- Big data
- Deep Tech
- SaaS
- MedTech
- Mestalla, València, Spain
Jump to section
Company mission
To transform healthcare and improve human lives through AI-guided precision solutions.
Our take
Quibim develops quantitative biomarkers, companion diagnostics and other imaging tools for systems biology applications, from immuno-oncology to neurology. Specialising in advanced whole-body medical imaging, the company’s innovative AI-guided image analysis unlocks imaging data that enables doctors to make the best value-based care decisions for their patients.
The company’s algorithms find abnormalities and biomarkers in X-rays, CT scans, and PET scans to detect disease early. The company leads real-world evidence (RWE) projects with over 10 million de-identified research imaging registries from 50,000+ oncology patients.
Its also reached a significant milestone with its QP-Prostate software, earning FDA 150(k) clearance, UKCA certification, and a CE mark, further solidifying its position in the market. Coupled with a successful Series A funding round, the company is now ready to expand its presence in the US while continuing to build on its success in Europe. With these accomplish,nets, Quibim is in a position for even greater growth and innovation in the future.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 8 rounds)
Jan 2025
$50m
SERIES A
Nov 2021
$5.4m
SEED
Total funding: $66.8m
This company has top investors
Leadership
Dr. Ángel Alberich-Bayarri
(Co-Founder & CEO)Previously spent nearly 7 years at Quirónsalud as a Research Engineer, R&D Scientific Coordinator and Biomedical Engineering Coordinator.